FOXP4 has been demonstrated to play an important role in the progression of multiple cancers, such liver cancer and oral squamous cell carcinoma, and breast cancer (Qi et al.; Xu et al.; Ma et al.); however, its function in bladder cancer remains unknown. Here, FOXP4 is linked to urinary bladder carcinoma.